Guillardia theta is a cryptomonad alga, whose phototrophic symbiont was acquired by secondary endocytobiosis. The nucleomorph, the vestigial nucleus of the eukaryotic endosymbiont, harbors three linear chromosomes with a total coding capacity of 515 kb. Sequencing of the nucleomorph genome reveals that it encodes an ORF homologous to the bacterial cell division protein FtsZ, supporting the hypothesis that FtsZ is common in chloroplasts. We show that the nucleomorph-encoded ftsZ gene is transcribed. The transcript is polyadenylated and therefore shows features typical of eukaryotic transcripts. However, 3' processing of nucleomorph mRNA is inaccurate. Transcripts of nucleomorph genes in G. theta overlap with neighboring UTRs and coding regions. We demonstrate that the reading frame encoding NmFtsZ is not interrupted by introns. Subcellular localization of the protein reveals that FtsZ is localized exclusively in the chloroplast of G. theta, demonstrating that FtsZ is imported into the organelle.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s004380050887 | DOI Listing |
Front Immunol
January 2025
Division of Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY, United States.
While durable antibody responses from long-lived plasma cell (LLPC) populations are important for protection against pathogens, LLPC may be harmful if they produce antibodies against self-proteins or self-nuclear antigens as occurs in autoimmune diseases such as systemic lupus erythematosus (SLE). Thus, the elimination of autoreactive LLPC may improve the treatment of antibody-driven autoimmune diseases. However, LLPC remain a challenging therapeutic target.
View Article and Find Full Text PDFCrohns Colitis 360
January 2025
Division of Digestive Diseases and Nutrition, Department of Medicine, University of Kentucky College of Medicine, Lexington, KY, USA.
Background: Despite advancements in the therapeutic armamentarium for Crohn's disease (CD), biologic and small molecule monotherapies are associated with sub-optimal response and remission rates. Utilizing dual biologic therapy (DBT) holds the potential to increase efficacy in the treatment of refractory or partially responsive CD. Evidence pertaining to this strategy remains limited.
View Article and Find Full Text PDFJ Food Sci Technol
January 2025
Grain Science and Technology Division, Defence Food Research Laboratory, Mysore, Karnataka 570011 India.
This study aimed to compare thirteen different varieties of hyacinth beans analyzedfor their nutritional and antinutritional constituents. The study classified HA-3, HA-4, and Kadale Avare as Lignosus varieties, while the remaining varieties Arka, Pusa, CO, and NS, were classified as Typicus. The protein content ranged from 19.
View Article and Find Full Text PDFToxicol Rep
June 2025
Division of Molecular Medicine, Bose Institute, P-1/12, CIT Scheme VII M, Kolkata, West Bengal 700054, India.
Alzheimer's Disease (AD) is one of the leading neurodegenerative diseases that affect the human population. Several hypotheses are in the pipeline to establish the commencement of this disease; however, the amyloid hypothesis is one of the most widely accepted ones. Amyloid plaques are rich in Amyloid Beta (Aβ) proteins, which are found in the brains of Alzheimer's patients.
View Article and Find Full Text PDFMol Ther Methods Clin Dev
March 2025
Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55902, USA.
Lipid nanoparticles (LNPs) are often liver tropic, presenting challenges for LNP-delivered mRNA therapeutics intended for other tissues, as off-target expression in the liver may increase side effects and modulate immune responses. To avoid off-target expression in the liver, miR-122 binding sites have been used by others in viral and non-viral therapeutics. Here, we use a luciferase reporter system to compare different copy numbers and insertion locations of miR-122 binding sequences to restrict liver expression.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!